Literature DB >> 12876135

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.

Lynne Warner Stevenson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12876135     DOI： 10.1161/01.CIR.0000078348.44634.BA

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  21 in total

1.  Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure.

Authors:  Lynne Warner Stevenson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

Review 2.  Beta-blocker use in decompensated heart failure.

Authors:  Rami Alharethi; Ray E Hershberger
Journal:  Curr Heart Fail Rep       Date:  2006-06

Review 3.  Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents.

Authors:  Marco Metra; Luca Bettari; Valentina Carubelli; Silvia Bugatti; Alessandra Dei Cas; Francesca Del Magro; Valentina Lazzarini; Carlo Lombardi; Livio Dei Cas
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

4.  Role of inotropic agents in the treatment of heart failure.

Authors:  Joshua I Goldhaber; Michele A Hamilton
Journal:  Circulation       Date:  2010-04-13       Impact factor: 29.690

Review 5.  The cardiorenal syndrome: lessons from the ADHERE database and treatment options.

Authors:  J Thomas Heywood
Journal:  Heart Fail Rev       Date:  2004-07       Impact factor: 4.214

6.  Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.

Authors:  Motoya Hayase; Federica Del Monte; Yoshiaki Kawase; Briain D Macneill; Jennifer McGregor; Ryuichi Yoneyama; Kozo Hoshino; Tsuyoshi Tsuji; Alec M De Grand; Judith K Gwathmey; John V Frangioni; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06       Impact factor: 4.733

Review 7.  Why, when, and how to assess pulmonary congestion in heart failure: pathophysiological, clinical, and methodological implications.

Authors:  Eugenio Picano; Luna Gargani; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

8.  Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.

Authors:  Federica del Monte; Djamel Lebeche; J Luis Guerrero; Tsuyoshi Tsuji; Angelia A Doye; Judith K Gwathmey; Roger J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

Review 9.  Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

Authors:  John R Teerlink; Marco Metra; Valerio Zacà; Hani N Sabbah; Gadi Cotter; Mihai Gheorghiade; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

Review 10.  Management of end-stage heart failure: a perspective on the Arab Gulf states.

Authors:  Waleed Al Habeeb; Garrick C Stewart; Gilbert H Mudge
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.